Thomas Stephen Basil - Insider Non-Derivative Transactions at Eliem Therapeutics, Inc. (ELYM) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 27, 2024, Thomas Stephen Basil's relationship to Eliem Therapeutics, Inc. (ELYM) is Director, and currently has 103,907 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ELYM insiders.
Data Source: SEC.
Thomas Stephen Basil - Insider Non-Derivative Transactions at ELYM
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 28, 2024 | Acquisition -- (Common Stock) | 103907 | 0 | 103907 |